Microbiota and HDL metabolism

Area of Science:

• Microbiology
• Metabolism
• Cardiovascular Science

Background:

• The gut microbiota's role in host health is established, but its specific impact on high-density lipoprotein (HDL) metabolism is not well understood.
• HDL metabolism modulation is a potential therapeutic strategy for preventing cardiovascular diseases.

Purpose of the Study:

• To review recent advancements in understanding the association between gut microbiota and host HDL metabolism.
• To explore the causality, mechanisms, and clinical applications of targeting the gut microbiota for HDL modulation.

Main Methods:

• Review of recent human and animal studies.
• Analysis of signaling molecules produced by gut microbiota.
• Exploration of reverse cholesterol transport and HDL function.

Main Results:

• Gut microbiota composition significantly influences individual variations in blood lipid profiles.
• Microbiota-derived signaling molecules impact reverse cholesterol transport and HDL function.
• Gut microbiota manipulation shows promise for improving HDL function and reducing cardiovascular risk.

Conclusions:

• The gut microbiota, a newly recognized endocrine organ, influences HDL metabolism and atherosclerosis.
• Targeting the gut microbiota presents a potential therapeutic avenue for enhancing HDL function and managing cardiovascular diseases.
• Further research is needed to identify specific bacterial targets and metabolites for therapeutic intervention.